Eyestem

Eyestem is a startup founded in 2018 based in India. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Eyestem develops scalable cell replacement therapies using induced pluripotent stem cells to treat incurable diseases, with a focus on replacing damaged photoreceptor cells in the eye to restore vision for conditions like dry age-related macular degeneration.